Flow-focusing regimes for accelerated production of monodisperse drug-loadable microbubbles toward clinical-scale applications.
Flow-focusing regimes for accelerated production of monodisperse drug-loadable microbubbles toward clinical-scale applications.
复制标题
DOI:
10.1039/c3lc51016f
复制
发表时间:
2013-12-21
期刊:
影响因子:
6.1
通讯作者:
Lee AP
中科院分区:
文献类型:
--
作者:
Shih R;Bardin D;Martz TD;Sheeran PS;Dayton PA;Lee AP
Ultrasound imaging often calls for the injection of contrast agents, micron-sized bubbles which echo strongly in blood and help distinguish vascularized tissue. Such microbubbles are also being augmented for targeted drug delivery and gene therapy, by the addition of surface receptors and therapeutic payloads. Unfortunately, conventional production methods yield a polydisperse population, whose nonuniform resonance and drug-loading are less than ideal. An alternative technique, microfluidic flow-focusing, is able to produce highly monodisperse microbubbles with stabilizing lipid membranes and drug-carrying oil layers. However, the published 1 kHz production rate for these uniform drug bubbles is very low compared to conventional methods, and must be improved before clinical use can be practical. In this study, flow-focusing production of oil-layered lipid microbubbles was tested up to 300 kHz, with coalescence suppressed by high lipid concentrations or inclusion of Pluronic F68 surfactant in the lipid solution. The transition between geometry-controlled and dripping production regimes was analysed, and production scaling was found to be continuous, with a power trend of exponent ~5/12 similar to literature. Unlike prior studies with this trend, however, scaling curves here were found to be pressure-dependent, particularly at lower pressure-flow equilibria (e.g. <15 psi). Adjustments in oil flow rate were observed to have a similar effect, akin to a pressure change of 1–3 psi. This analysis and characterization of high-speed dual-layer bubble generation will enable more-predictive production control, at rates practical for in vivo or clinical use.
登录
查看更多内容
影响因子:
4.6
作者:
Anna, Shelley L.;Mayer, Hans C.
通讯作者:
Mayer, Hans C.
影响因子:
4.2
作者:
Forsberg, F;Shi, WT;Goldberg, BB
通讯作者:
Goldberg, BB
影响因子:
2.3
作者:
Kang, Juan;Wu, Xiaoling;Zhang, Yong
通讯作者:
Zhang, Yong
影响因子:
4.6
作者:
Cubaud, T;Ho, CM
通讯作者:
Ho, CM
影响因子:
2.3
作者:
Li, Xingsheng;Wang, Zhigang;Xu, Chuanshan
通讯作者:
Xu, Chuanshan